Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Wicker

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
The Journal of Experimental Medicine|November 1, 1994
Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetesL S Wicker, J A Todd, J B Prins, et al.
The Journal of Experimental Medicine|June 1, 1987
Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouseL S Wicker, B J Miller, L Z Coker, et al.
Nature|September 19, 1991
Type 1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/Ity/Bcg genes on chromosome 1R J Cornall, J B Prins, J A Todd, et al.
Diabetes|October 27, 2001
Mapping by genetic interaction: high-resolution congenic mapping of the type 1 diabetes loci Idd10 and Idd18 in the NOD mouseP A Lyons, N Armitage, C J Lord, et al.
Endocrinology|January 1, 1992
Pancreatic islet ganglioside expression in nonobese diabetic mice: comparison with C57BL/10 mice and changes after autoimmune beta-cell destructionF Dotta, L B Peterson, M Previti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1997
Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1P L Podolin, P Denny, C J Lord, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligandsA B Jones, J J Acton, A D Adams, et al.
Genetics|May 3, 2001
Statistical modeling of interlocus interactions in a complex disease: rejection of the multiplicative model of epistasis in type 1 diabetesH J Cordell, J A Todd, N J Hill, et al.
The Journal of Experimental Medicine|July 11, 1992
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetesL S Wicker, M C Appel, F Dotta, et al.
Cytokine|June 17, 2000
Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene?P L Podolin, M B Wilusz, R M Cubbon, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Experimental Medicine|November 1, 1994
Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetesL S Wicker, J A Todd, J B Prins, et al.
The Journal of Experimental Medicine|June 1, 1987
Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouseL S Wicker, B J Miller, L Z Coker, et al.
Nature|September 19, 1991
Type 1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/Ity/Bcg genes on chromosome 1R J Cornall, J B Prins, J A Todd, et al.
Diabetes|October 27, 2001
Mapping by genetic interaction: high-resolution congenic mapping of the type 1 diabetes loci Idd10 and Idd18 in the NOD mouseP A Lyons, N Armitage, C J Lord, et al.
Endocrinology|January 1, 1992
Pancreatic islet ganglioside expression in nonobese diabetic mice: comparison with C57BL/10 mice and changes after autoimmune beta-cell destructionF Dotta, L B Peterson, M Previti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1997
Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1P L Podolin, P Denny, C J Lord, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligandsA B Jones, J J Acton, A D Adams, et al.
Genetics|May 3, 2001
Statistical modeling of interlocus interactions in a complex disease: rejection of the multiplicative model of epistasis in type 1 diabetesH J Cordell, J A Todd, N J Hill, et al.
The Journal of Experimental Medicine|July 11, 1992
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetesL S Wicker, M C Appel, F Dotta, et al.
Cytokine|June 17, 2000
Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene?P L Podolin, M B Wilusz, R M Cubbon, et al.
Pageof 6